Overview
Dipotassium phosphate (K2HPO4) is a highly water-soluble salt often used as a fertilizer and food additive as a source of phosphorus and potassium as well as a buffering agent.
Indication
Dipotassium phosphate is used in imitation dairy creamers, dry powder beverages, mineral supplements, and starter cultures as an additive. It is used in non-dairy creamers to prevent coagulation. Dipotassium phosphate is also used to make buffer solutions and it is used in the production of trypticase soy agar which is used to make agar plates for culturing bacteria.
Associated Conditions
- Electrolyte imbalance
- Mild Metabolic acidosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Baxter Healthcare Company | 0338-0210 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-0210 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| King Bio Inc. | 57955-9003 | ORAL | 10 [hp_X] in 59 mL | 5/19/2025 | |
| Baxter Healthcare Company | 0338-1147 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1147 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Company | 0338-1142 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1142 | INTRAVENOUS | 261 mg in 100 mL | 9/21/2020 | |
| The Wellness Center | 50181-0030 | ORAL | 1 [hp_M] in 1 mL | 5/28/2025 | |
| Bestmade Natural Products | 82969-9015 | ORAL | 6 [hp_X] in 6 [hp_X] | 3/23/2025 | |
| Bestmade Natural Products | 82969-9026 | ORAL | 6 [hp_X] in 6 [hp_X] | 3/23/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Trainade Lemon Lime | 380939 | Medicine | A | 12/16/2021 | |
| SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 25% 1000mL injection AHB6350 | 19609 | Medicine | A | 9/30/1991 | |
| BLACKMORES NUTRITIONAL COMPOUNDS M.L. 20 | 137809 | Medicine | A | 4/24/2007 | |
| Swisse Ultiboost Magnesium + Sleep Powder | 313001 | Medicine | A | 1/8/2019 | |
| MSP Magnesium | Sleep | Pain | 431019 | Medicine | A | 12/18/2023 | |
| Trainade Hydration (Orange & Mango Flavour) | 396471 | Medicine | A | 9/27/2022 | |
| Swisse Ultiboost Mega B+ | 223284 | Medicine | A | 5/8/2014 | |
| Trainade Hydration Raspberry Lemonade | 449746 | Medicine | A | 5/28/2024 | |
| Trainade Hydration (Pineapple Flavour) | 423190 | Medicine | A | 9/29/2023 | |
| Liquid I.V. Hydration Multiplier Passionfruit | 423890 | Medicine | A | 10/4/2023 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | baxter corporation clintec nutrition division | N/A | Solution - Intravenous | 261 MG / 100 ML | 12/31/1996 |
| 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. | clintec nutrition company | 02143240 | Liquid - Intravenous | 261 MG / 100 ML | 12/31/1996 |
| 4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. | clintec nutrition company | 02143224 | Liquid - Intravenous | 261 MG / 100 ML | 12/31/1996 |
| HP17 TAB | 01975781 | Tablet - Oral | 6 X | 10/4/1996 | |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX | baxter corporation clintec nutrition division | 02013975 | Solution - Intravenous | 130.5 MG / 100 ML | 12/31/1993 |
| CLINIMIX E | baxter corporation | 02013967 | Solution - Intravenous | 261 MG / 100 ML | 12/31/1993 |
| 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | baxter corporation clintec nutrition division | 02142368 | Solution - Intravenous | 261 MG / 100 ML | 12/31/1996 |
| INSTILLATION MEDIUM FOR IMMUCYST | aventis pasteur limited | 01974505 | Liquid - Intravesicular | 75 MG / 50 ML | 12/31/1994 |
| KALI PHOS TAB 60MG | biocentre | 00570249 | Tablet - Oral | 60 MG / TAB | 12/31/1984 |
| ACIDUM PHOSPHORICUM PLEX | seroyal international inc. | 02233076 | Pellet
,
Tablet
,
Drops
,
Syrup
,
Granules
,
Liquid - Oral | 2 X | 4/6/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.